Example: Heart Attack

Search clinical trials for: Hallucinogens

Total 260 results

    • NCT02033707
      Completed
      Effects of Hallucinogens and Other Drugs on Mood and Performance
      Conditions: Healthy
    • NCT04040582
      Recruiting
      Psychedelics and Wellness Study (PAWS)
      Conditions: Depression, Anxiety, PTSD
    • NCT04661514
      Recruiting
      Exploring the Safety, Tolerability, and Preliminary Efficacy of Psychedelic-Assisted Psychotherapy for Anorexia
      Conditions: Anorexia Nervosa
    • NCT04410913
      Not yet recruiting
      Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
      Conditions: Alcohol Use Disorder
    • NCT04123314
      Recruiting
      Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
      Conditions: Depressive Symptoms; Depression; Alzheimer Disease; Mild Cognitive Impairment
    • NCT00957359
      Completed
      Psilocybin Cancer Anxiety Study
      Conditions: Cancer
    • NCT02037126
      Recruiting
      Psilocybin-facilitated Treatment for Cocaine Use
      Conditions: Cocaine-Related Disorders
    • NCT04522804
      Not yet recruiting
      Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer
      Conditions: Cancer
    • NCT04673383
      Not yet recruiting
      SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients
      Conditions: Major Depressive Disorder
    • NCT03866174
      Recruiting
      A Study of Psilocybin for Major Depressive Disorder (MDD)
      Conditions: Depressive Disorder, Major
    • NCT04593563
      Recruiting
      The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
      Conditions: Major Depressive Disorder
    • NCT04280055
      Recruiting
      Prophylactic Effects of Psilocybin on Chronic Cluster Headache
      Conditions: Cluster Headache
    • NCT01988311
      Completed
      Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
      Conditions: Psilocybin; Hallucinogens; Pharmacologic Actions; Central Nervous System Agents; Therapeutic Uses; Psychotropic Drugs
    • NCT03300947
      Suspended
      Psilocybin for Treatment of Obsessive Compulsive Disorder
      Conditions: Obsessive-compulsive Disorder (OCD)
    • NCT04718792
      Not yet recruiting
      Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
      Conditions: Alcohol Use Disorder (AUD)
    • NCT04141501
      Recruiting
      Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients
      Conditions: Alcohol Use Disorder
    • NCT03781128
      Recruiting
      Lysergic Acid Diethylamide (LSD) as Treatment for Cluster Headache
      Conditions: Cluster Headache
    • NCT03356483
      Recruiting
      Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
      Conditions: Obsessive-Compulsive Disorder
    • NCT04501653
      Not yet recruiting
      Precision Functional Brain Mapping in Psilocybin
      Conditions: Psilocybin
    • NCT04656301
      Not yet recruiting
      Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder
      Conditions: Body Dysmorphic Disorders
    • NCT04505189
      Not yet recruiting
      Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study
      Conditions: Anorexia Nervosa
    • NCT04433858
      Not yet recruiting
      An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
      Conditions: Treatment Resistant Depression
    • NCT04433845
      Not yet recruiting
      The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
      Conditions: Treatment Resistant Depression
    • NCT04218539
      Not yet recruiting
      Repeat Dosing of Psilocybin in Migraine Headache
      Conditions: Migraine Headache
    • NCT04161066
      Recruiting
      Adjunctive Effects of Psilocybin and Buprenorphine
      Conditions: Opioid Use Disorder
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations